Many patients with heart failure remain symptomatic despite optimal drug therapy. Resynchronisation using a biventricular pacemaker has been proven in clinical trials to improve symptoms and life expectancy. Although these devices are relatively expensive, this treatment is cost effective, and should be employed more often than is currently the case in the UK, explains Professor Martin Cowie.